These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7375348)

  • 1. [Diclofurime, a new major hypotensive agent. Clinical study in 24 patients (author's transl)].
    Letac B; Chevallier B; Cribier A; Barthes P
    Nouv Presse Med; 1980 Mar; 9(10):701-4. PubMed ID: 7375348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diclofurime: a new antihypertensive agent. Effectiveness and kidney tolerance].
    Godin M; Fillastre JP; Revert C; Borsa F; Reumont G; Viotte G
    Arch Mal Coeur Vaiss; 1981 Jun; 74 Spec No():79-89. PubMed ID: 6794531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical experience with prazosin hydrochloride in arterial hypertension.
    Turner AS; Watson O; Peel JS
    N Z Med J; 1975 Mar; 81(535):240-2. PubMed ID: 1055318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Long term treatment with acebutolol in hypertension (author's transl)].
    Fogari R; Jemoli R; Del Mastro S; Sega R
    G Ital Cardiol; 1979; 9(11):1280-7. PubMed ID: 399933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomised crossover comparison of reserpine and sustained-release nifedipine in hypertension.
    Manyemba J
    Cent Afr J Med; 1997 Dec; 43(12):344-9. PubMed ID: 9631111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of combination therapy with valsartan/hydrochlorothiazide in the initial treatment of severe hypertension.
    Calhoun DA; Glazer RD; Pettyjohn FS; Coenen PD; Zhao Y; Grosso A
    Curr Med Res Opin; 2008 Aug; 24(8):2303-11. PubMed ID: 18593517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acebutolol and nifedipine in the treatment of arterial hypertension: efficacy and acceptability.
    de Divitiis O; Petitto M; Di Somma S; Fazio S; Galderisi M; Villari B; Liguori V; Santomauro M
    Arzneimittelforschung; 1984; 34(6):710-5. PubMed ID: 6386007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study of rapidity of hypotensive effects of acebutolol on non hospitalized patients (author's transl)].
    Meisel C; Destreguil D; Godeau P
    Sem Hop; 1978 Oct 8-15; 54(29-32):925-8. PubMed ID: 216082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Nebivolol, a third generation beta blocker: the modern treatment of hypertension. Results of a multicentric observational study].
    von Fallois J; Faülhaber HD
    Fortschr Med Orig; 2000 Jul; 118 Suppl 2():77-82. PubMed ID: 15700490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
    Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
    Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha 1-blockade for the treatment of hypertension: a megastudy of terazosin in 2214 clinical practice settings.
    Itskovitz HD
    Clin Ther; 1994; 16(3):490-504. PubMed ID: 7923316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of renin after betablocking diuretic and vasodilator treatment in essential hypertension (author's transl)].
    Lombardo M; Fusco M; Valente D
    G Ital Cardiol; 1979; 9(12):1363-70. PubMed ID: 45015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy with hydrazinopyridazine, a new antihypertensive vasodilatory agent, in combination with beta-receptor blocking substances.
    Kirch W; von Gizycki C
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(5):233-5. PubMed ID: 6104636
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy and tolerability of manidipine hydrochloride in the long-term treatment of mild-moderate hypertension. Manidipine Efficacy in Long-Term Treatment Group.
    Fogari R; Zoppi A; Lusardi P; Mugellini A
    Blood Press Suppl; 1996; 5():24-8. PubMed ID: 8973789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The comparison of clinical effectiveness of perindopril and acebutolol in the primary hypertension treatment].
    Pieniazek W; Franczuk P; Janicki K
    Przegl Lek; 2001; 58(5):411-4. PubMed ID: 11603173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of trandolapril alone or in combination with a calcium channel blocker in hypertensive patients over 60 years of age].
    Gosse P; Vaur L; Dutrey-Dupagne C; Genes N; Destrée D; Elkik F
    Ann Cardiol Angeiol (Paris); 1995 Nov; 44(9):517-24. PubMed ID: 8745662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acebutolol in the treatment of arterial hypertension. Clinical study].
    Lucsko M; Chaignon M; Guédon J
    Nouv Presse Med; 1975 Dec; 4(46 Suppl):3287-9. PubMed ID: 768911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of the perindopril/indapamide combination therapy for hypertension: the PRIMUS study.
    Holzgreve H; Risler T; Trenkwalder P
    Curr Med Res Opin; 2006 Sep; 22(9):1849-58. PubMed ID: 16968588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eprosartan provides safe and effective long-term maintenance of blood pressure control in patients with mild to moderate essential hypertension.
    Levine B
    Curr Med Res Opin; 2001; 17(1):8-17. PubMed ID: 11464450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.